REQUEST A DEMO
Total
USD $0.00
Search more companies

"Euroimmun Polska" Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: "Euroimmun Polska" Sp. z o.o. Profile Updated: August 17, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

EUROIMMUN POLSKA Sp. z o.o. is a company that specializes in serological systems for detecting antibodies in cases of suspected bacterial infection, including ELISA, CHLIA, IIFT, immunoblot, and EUROMicroblot. The company has also developed a new generation of ELISA testing systems for brain fluid labeling in collaboration with ADx Neuroscience.

Headquarters
Ul. Widna 2A
Wroclaw; Dolnoslaskie; Postal Code: 50-543

Contact Details: Purchase the "Euroimmun Polska" Sp. z o.o. report to view the information.

Website: http://www.euroimmun.pl

Basic Information
Total Employees:
Purchase the "Euroimmun Polska" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Euroimmun Polska" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Euroimmun Polska" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Euroimmun Polska" Sp. z o.o. report to view the information.
Incorporation Date:
May 18, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after "Euroimmun Polska" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
22.1%
Total operating revenue
21.97%
Operating profit (EBIT)
27.34%
EBITDA
25.14%
Net Profit (Loss) for the Period
35.82%
Total assets
19.83%
Total equity
14.02%
Operating Profit Margin (ROS)
0.4%
Net Profit Margin
0.75%
Return on Equity (ROE)
1.97%
Quick Ratio
-2%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?